CRT provides commercialisation services to both Cancer Research UK and oncology institutes worldwide, as well as operating our own drug discovery laboratories (CRT-DL).
We are driven to address unmet needs in cancer through innovative initiatives such as Clinical Development Partnerhips (CDP) and the theme-based approach of CRT-DL. The ultimate aim of such initiatives is to bring breakthrough therapeutics to cancer patients sooner.
CRT Business Development Managers help researchers identify and develop their most commercially and clinically promising projects.
Our flexible approach to commercialisation enables us to work with a diverse range of commercial and academic organisations.
We aim to bring breakthrough therapeutics to cancer patients sooner through initiatives such as Clinical Development Partnerships.
We've expanded our licensing portfolio in imaging and diagnostics, one of the most effective means of detecting cancer.
We can propel promising research to the next stage by helping scientists access appropriate translational funding and in-kind support.